Company: MLSS
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001493152-25-022276
Chunk: 119

Company: MILESTONE SCIENTIFIC INC.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 4
Chunk 119
---
 U.S. trade policy to further evaluate key aspects
of U.S. trade policy further. There has been and are ongoing discussions and commentaries regarding potential significant changes to
U.S. trade policies, treaties, and tariffs. There exists significant uncertainty about the future relationship between the U.S. and
other countries with respect to such trade policies, treaties, and tariffs. These developments, or the perception that any of them
could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may
significantly reduce global trade and, in particular, trade between the impacted nations and the U.S. We source essential elements
used in our products from China. We have significant sales in jurisdictions outside the United States. Any of these factors could
depress economic activity and restrict our access to suppliers or customers and have a material adverse effect on our business,
financial condition, and results of operations.

Government
Action on tariffs, and other funding, may impede our ability to conduct our research and to raise capital.

Early
2025 federal government actions to impose tariffs and limit research grants and other funding, including funding for universities
and research enterprises, may cause disruption to our business. These actions include the imposition of tariffs and ending or
restructuring government research funding generally or in conjunction with higher learning institution funding. These government
actions have been only recently implemented; therefore, the full impact has yet to be realized by the Company. Nonetheless, (i)
tariffs are likely to increase the cost of doing business and to make it more difficult to obtain items where imported equipment is
required by our own activities and the activities of our collaborative and research partners, and (ii) ending or reducing research
funding is likely to make it more challenging to find collaborative research partners to work with us as government funding is an
indirect support for our research and product development activities.  We also believe that as research funding impacts our
collaborative research partners is reduced or withdrawn, it will make raising capital for the Company more difficult, as investors
will want to know if the Company will be able to use the proceeds with fully funded entities for product development.

Item
1B. Unresolved Staff Comments

None.

 27 

Item
1C. Cybersecurity

None.

Item
2. Unregistered Sales of Equity Securities and use of proceeds

Not
applicable.

Item 3.
Default upon Senior Securities

Not
applicable.

Item 4.
Mine Safety Disclosure